Publication | Closed Access

The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis

Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyCardiovascular DiseaseNonalcoholic Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseMetabolic DiseaseDiabetesLiver PhysiologySubclinical AtherosclerosisMetabolic DisorderProspective AnalysisFatty Liver DiseaseMedicineAtherosclerosisEpidemiologyHealth Sciences